02.03.2013 Views

198 Topics in Current Chemistry Editorial Board: A. de Meijere KN ...

198 Topics in Current Chemistry Editorial Board: A. de Meijere KN ...

198 Topics in Current Chemistry Editorial Board: A. de Meijere KN ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

44 J.P. Glusker<br />

bond<strong>in</strong>g capabilities of the two compounds are different. Methotrexate is found<br />

<strong>in</strong> a cavity 15 Å <strong>de</strong>ep <strong>in</strong> the E. coli enzyme complex. The entire <strong>in</strong>hibitor molecule<br />

is bound by a system of hydrogen bond and hydrophobic <strong>in</strong>teractions. A<br />

similar b<strong>in</strong>d<strong>in</strong>g is found for the E. coli and L. casei enzyme complexes.<br />

The enzyme promotes hydri<strong>de</strong> transfer from NADPH to the pter<strong>in</strong> r<strong>in</strong>g. This<br />

is facilitated by the <strong>de</strong>velopment of a charge on C6 and by protonation of N5. The<br />

absolute configuration of tetrahydrofolate has been established [89, 90] to be S<br />

at C6, but if dihydrofolate is bound <strong>in</strong> the same orientation as methotrexate, the<br />

configuration should be R, as shown <strong>in</strong> Fig. 35. When dihydrofolate (or tetrahydrofolate)<br />

is bound <strong>in</strong> the enzyme <strong>in</strong> the same way as methotrexate, the hydrogen<br />

atom that is transferred to NADPH is po<strong>in</strong>t<strong>in</strong>g <strong>in</strong> the wrong direction. Thus<br />

dihydrofolate and methotrexate must b<strong>in</strong>d to the enzyme with different orientations<br />

as established later by X-ray crystallographic studies. Studies of additional<br />

bound substrate analogues and <strong>in</strong>hibitors [91, 92] confirm that b<strong>in</strong>d<strong>in</strong>g <strong>in</strong><br />

the active site of the enzyme is governed ma<strong>in</strong>ly by hydrogen bond<strong>in</strong>g, and not<br />

simply by molecular shape. These situations are illustrated <strong>in</strong> Fig. 36. They show<br />

that substrate and <strong>in</strong>hibitor have different and unique b<strong>in</strong>d<strong>in</strong>g preferences and<br />

therefore the fact that their mo<strong>de</strong>s of b<strong>in</strong>d<strong>in</strong>g are different could have been<br />

predicted from our un<strong>de</strong>rstand<strong>in</strong>g of donor and acceptor roles <strong>in</strong> hydrogen<br />

bond<strong>in</strong>g (see also the article by A. Naugia and G.R. Desiraju <strong>in</strong> this volume).<br />

9.2<br />

B<strong>in</strong>d<strong>in</strong>g of Drugs to Nucleic Acids<br />

Antitumor agents that <strong>in</strong>teract with DNA do so <strong>in</strong> one of three ways.<br />

1. Intercalation between the nucleic acid bases of DNA. This mo<strong>de</strong> of b<strong>in</strong>d<strong>in</strong>g is<br />

found for anthracycl<strong>in</strong>es, act<strong>in</strong>omyc<strong>in</strong> D and acrid<strong>in</strong>es. The DNA backbone<br />

flexes so that the bases, normally separated by 3.4 Å, are moved to approximately<br />

7 Å apart. As a result, a flat aromatic molecule can slip between them.<br />

a<br />

Fig. 36 a – c. B<strong>in</strong>d<strong>in</strong>g <strong>in</strong> dihydrofolate reductase [88]: a b<strong>in</strong>d<strong>in</strong>g of the pter<strong>in</strong> r<strong>in</strong>g of methotrexate<br />

<strong>in</strong> crystals of the Lactobacillus casei enzyme

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!